Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes

Abstract

Catalytic iron identified all patients with acute MI at presentation and serial elevation was independently associated with MACE. This biomarker of vascular injury is useful in the rapid serologic assessment of patients with suspected ACS.